Pneumocystis jirovecii is known to cause opportunistic infections in the lower respiratory tract in individuals with low immune systems, especially patient with HIV infection. The prevalence of P. jirovecii pneumonia (PjP) in various countries show varying numbers. In Indonesia, HIV cases continue to rise. However, the data in Indonesia concerning the case of PjP is very limited. Until now the prevalence of PjP in Indonesia is only based on clinical symptoms of the patient. Currently, diagnosis of PjP relies on microscopic examination. The disadvantage of this examination is not easy to do and has a high negative predictive value. Thus, this study was conducted to develop a molecular test to diagnose PjP infection in HIV-AIDS suspected pneumonia. Molecular diagnostic test aimed for Major Surface Glycoprotein (MSG) gene of P. jirovecii detection was done through real-time PCR against 100 sputum samples. Demographic data show that the prevalence of PjP infection in HIV-AIDS suspected pneumonia patients in Jakarta is 20.0%, male 75% within 31-40 y.o (35%), dominant (80%) from patients with CD 4+ T-lymphocytes of 200-349 cells/µL. Molecular real-time PCR methods were shown to give five times sensitivity higher than Giemsa stain.
Introduction
Pneumocystis jirovecii is known to cause opportunistic infections in the lower respiratory tract in individuals with weakened immune systems, especially patients with infection HIV 1 . Individuals with an intact immune system will control the primary infection and the microorganisms will remain latent in the lung. Disease will occur when the immune system is disrupted or deficient. In this case, it is possible to find the cause of clinical pneumonia in respiratory tract 2,3 . 
IC-BIOLIS
International epidemiologic survey showed that pneumonia distributed worldwide with antibody prevalence varies among different geographical areas and can attack human at various ages 4, 5 . The prevalence of PjP in various countries showed varying numbers. In Indonesia, HIV cases continue to rise. However, the data in Indonesia concerning the case of the PjP is very limited, until now the prevalence of PjP in Indonesia is only based on clinical symptoms of patients in the amount of 13.4% as reported by Lydia et al. (2009) . In the same year at other hospitals in Indonesia (RS Persahabatan and the RSCM), 14.55% of the PjP was found in 55 patients studied. The figure is lower than the state other countries 6, 7 .
Inadequate diagnostic facilities cause PjP incidence data in Indonesia is not known with certainty. Currently in Indonesia, raw diagnostic standard for the diagnosis of PjP is not available, resulting in undetected cases. This can occur because, despite the many studies done, successful breeding of Pneumocystis jirovecii is very limited, so that its life cycle is not yet fully understood 8 .
Until now, diagnosis of PjP relies on microscopic examination of respiratory specimens such as bronchial washings fluid (bronchoalveolar lavage/BAL), sputum induction or sputum 8 . The disadvantage of this examination is not easy to do and has a high negative predictive value. 9 This study conducted real-time PCR detection for gene Major Surface Glycoprotein (MSG) as a rapid diagnosis of infection with P. jirovecii. Hopefully this research can be applied to diagnose infection with P. jirovecii thereby assisting in the management of HIV patients with pneumonia symptoms quickly and accurately.
Methods
Hundreds of sputum that have been obtained is mixed with ditiotreitol (Sputolysin;
Behring Diagnostics), and vortexed for 30 seconds (Vortex Genie 2, Scientific Industries), followed by incubation in the incubator (Thermo Electron Corporation) with 35-37 ∘ C temperature for 15 minutes. After incubation, the specimen is mixed with phosphate buffered saline (pH 7.4) until the turbidity is equivalent to 0.5 Mc. Farland. The mixture was then vortexed for another 15 seconds. Furthermore specimen was centrifuged at 3000 RPM (Universal 320 R, Hettich Zentrifugen) at a temperature of 25 ∘ C for 5 minutes. The supernatant was discarded while the pellet (1 mL) was used for coloring Giemsa 10, 11, 12, 13 .
For real-time PCR test, the pellets were then centrifuged with a speed of 12000 RPM (Sorvall Biofuge Primo) at a temperature of 25 ∘ C for 5 minutes. Furthermore, the DOI 
Test microscopy with Giemsa Staining
Staining was done by using Giemsa staining Modification 17 . Microscopic tests were done by spreading the suspension of pellets above the glass pedestal to form a thin layer. This was then dried through aeration in open air. Following this, 95% ethyl alcohol was poured until it covered the entire surface of the preparation, and this was then left to dry. Furthermore Sulphation reagent is dripped onto the preparation and allowed to stand for 10 minutes, then washed with running water for 5 minutes. After this, the preparations were stained with Giemsa 10% for 30 minutes, before being washed with water and allowed to dry in the air. After drying, a drop of emersion oil was dripped on the preparation and then viewed under microscope with magnification of 10 x 100 18 .
DNA extraction Pneumocystis jirovecii
Extraction of specimens was performed in accordance with the procedures on extraction kit QIAmp DNA Mini Kit (Qiagen) as follows: Pellet from the processing of specimens was removed from the refrigerator to a temperature corresponding to room temperature. and CD 4+ 50-199 as many as 2 patients. 
Real-time PCR

Detection of P. jirovecii using the real-time PCR method
Detection of P. jirovecii using Giemsa Staining
Microscopic examination was performed with Giemsa staining modified with sulphation.
We obtained 3 positive samples of P. jirovecii ( Table 3) . One of the samples found a cyst form of this microorganism (Figure 2 ). Table 3 25, 26 . This age differences needs to be further examined as this study provide evidence of detection in both early and old age.
Comparison of real-time PCR and Giemsa microscopic
Based on the number of CD 4+ T-lymphocytes, the range of 200-349 occupies the highest percentage (80%). This is an interesting finding in this study beacuse many other studies mentioned that Pneumocystis pneumonia generally occurs in HIV patients with CD 4+ T-lymphocytes <200 cells/ µL 27, 28, 29, 30, 31 , whereas in this study, the number CD 4+
T-lymphocytes did not affect the presence of P jirovecii in patients. P jirovecii can be obtained from birth and occur through reactivation of altent infections when the immune system decrease. Several researchers have revealed that P. jirovecii transmission can be obtained from the enviroment, from infected people, and can also be transmitted from someone who has P. jirovecii colonization 32, 33, 34 . Giemsa staining that was modified using sulphation was found to improve the visualization of cyst shapes that was not detected in conventional Giemsa. This research has succeeded in getting a cyst shape in 1 of the 3 positive samples. Addition of sulphation which is addition of a mixture of sulfuric acid and glacial acetic acid before staining helped the Giemsa polychrome dye to react to opening the fungal cell wall and absorbsing dye so that the cyst can be clearly seen.
In terms of patients' gender distribution, male was found to be higher than female, with 66.66% and 33.33%, respectively. Distribution of patient's age was found to be proportionate, with 33.33% for each age range of 31-40, 41-50 and 51-60 years old.
Analysis of the CD 4+ T-lymphocytes showed that all patients were in the range of 200-349 cells/ µL. showed real-time PCR increased positive results compared to microscopy, respectively at 41% and 19% 35, 36, 37 . Major surface glycoproteins were chosen as targets because they have the most varied sequences found on the surface of fungal cells and are sustainable. Additionally, the MSG gene can increase sensitivity so that it is used by many researchers for detection 38, 39, 40, 41 .
Comparison of real-time PCR and Giemsa staining
Conclusion
The developed real-time PCR detection was able to provide better diagnostic value than Giemsa staining. Demographically, the prevalence of P. jirovecii in HIV-AIDS with pneumonia in Jakarta reached 20%, dominant in the range of CD 4+ T-lymphocytes 200-349 cells/ µL.
